glp-1 immune system Beyond metabolic benefits: The underexplored immunomodulatory effects of GLP -1/glucagon agonists Roles of glucagon-like peptide 1 – Gut immune cells have a

What good monitoring looks like Routine follow-up with your diabetes doctor Retinal monitoring based on your baseline eye disease severity Faster eye review if symptoms appear or worsen Coordination between endocrinology and ophthalmology if retinopathy is active For some patients, this may mean standard annual follow-up

Its also easier to store and transport, which means it could be more globally accessible than the injectable medications.

Furthermore, a new orally bioavailable GLP-1RA, oral hypoglycemic peptide 2 (OHP2), can confer protective effects on diabetic cardiomyopathy through rescuing cardiac lipotoxicity by inhibiting Rho (the small GTPase) kinase (ROCK)/PPAR pathway [89, 90] (Figure 1)

Targeted Treatment: Precision-focused on specific areas for superior results